Juan F. Granada, MD, president and chief executive officer of the Cardiovascular Research Foundation, previewed TCT 2022 for us, detailing what attendees can expect to see at the big show in Boston. 

Atrial secondary mitral regurgitation has been linked to higher in-hospital mortality and hospitalization rates. 

A 31-year-old patient developed acute myocarditis shortly after the onset of monkeypox symptoms. The team that treated him shared their story in a new case study.

All-cause mortality after five years is much more likely if a TAVR patient presents with CAD, according to a new analysis published in JACC: Cardiovascular Interventions.

“Religiosity and spirituality may serve as buffers to stress and have therapeutic effects," according to one Mayo Clinic cardiologist involved in the study. 

The new analysis, published in Circulation, confirmed that vaccine-related myocarditis is incredibly rare.

The National Heart, Lung and Blood Institute, part of the National Institutes of Health, awarded the funds to three research teams. 

A new survey of 40 health industry executives shows that digital transformation and staffing challenges top the list of C-suite priorities for the year ahead.